Nov 04, 2021 / 12:30PM GMT
Operator
Greetings, and welcome to the TG Therapeutics Third Quarter 2021 Earnings Call and Business Update. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jenna Bosco, Senior Vice President, Corporate Communications. Thank you, Jenna. You may begin.
Jenna Bosco - TG Therapeutics, Inc. - VP of IR & Senior VP of Corporate Communications
Thank you. Welcome, everyone, and thanks for joining us this morning. I'm Jenna Bosco, and with me today to discuss the third quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer.
Following our safe harbor statement, Mike will provide an overview of our recent corporate developments as well as provide an update on the current pivotal programs and key remaining goals for 2021. Adam will then provide an update on our commercialization efforts, and Sean will provide a brief overview of
Q3 2021 TG Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot